Product News
Ryvu Therapeutics Presents RVU305 (PRMT5i) and ONCO Prime Platform Data at the 2025 AACR-NCI-EORTC International Conference
Ryvu presents new data on PRMT5 inhibitor RVU305 and ONCO Prime discovery platform for next-generation cancer therapies.
Product News
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement To Develop Droplet Digital™ PCR High Complexity Assays
Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast cancer.
Product News
Syncell Expands European Market Presence To Advance Disease Research and Drug Discovery
Syncell’s Microscoop Mint debuts in Europe at Max Planck and VIB, advancing subcellular proteomics and disease research.
Product News
Aptamer Expands Into Targeted Radiopharmaceuticals With Major Top 3 Pharma Contract
Aptamer inks £360K deal with a top pharma to develop Optimer® radiopharmaceuticals targeting cancer.
Product News
Bio-Rad Extends Partnership With Gencurix Through Strategic Agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe
Bio-Rad to distribute Gencurix Droplex digital PCR cancer testing kits across Europe, advancing precision oncology diagnostics.
Product News
Integrated DNA Technologies and Hamilton Partner To Automate Customizable NGS Workflows and Accelerate Biomarker Discovery
IDT and Hamilton partner to automate NGS workflows, boosting cancer research efficiency and genomic discoveries.
Product News
Eppendorf Award 2026: Apply now
Applications are open for the 2026 Eppendorf Award, honoring young biomedical researchers in Europe with a €20,000 prize.
Product News
STREAM Consortium and Inocras Inc., Unveil Landmark National Pediatric Cancer WGS Program
Inocras’ STREAM Program delivers real-world precision oncology for children, with actionable results in most patients.
Product News
N4 Pharma Collaboration With SRI International Demonstrates Nuvec® Nanoparticle Successfully Targets Lung Cancer Cells
N4 Pharma and SRI show Nuvec® can precisely deliver RNA therapies to cancer cells, advancing targeted oncology treatments.
Product News
US Food and Drug Administration Authorizes CytoCell KMT2A Breakapart FISH Probe Kit PDx
FDA clears OGT’s CytoCell KMT2A probe as a companion diagnostic for Revuforj in relapsed or refractory acute leukaemia.
Advertisement